A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.

Andy Rose is stepping down as president and CEO of Worthington Enterprises, a year after leading the company's split from Worthington Industries. Joseph Hayek, the company's executive vice ...

The founding CEO of Alnylam Pharmaceuticals Inc. is now leading the charge with newly launched City Therapeutics Inc., which just completed a $135 million series A financing. City’s executive chair, ...

The founding CEO of Alnylam Pharmaceuticals Inc. is now leading the charge with newly launched City Therapeutics Inc., which just completed a $135 million series A financing. City’s executive chair, ...

MILAN, Oct 21 (Reuters) - Italy's government will present a state-backed company that will build advanced nuclear reactors in the country before the end of the year, the industry minister said on ...

Rights May 14, 1993 Jun 15, 1993 Sep 30, 1993 Rights ratio: 2 share for every 1 held at a price of Rs 10.0 Rights May 14, 1993 Jun 15, 1993 Mar 30, 1993 Rights ratio: 2 share for every 1 held at a ...

B. Riley will receive $203 million in cash and $183 million in preferred units, while retaining a 47% equity stake in the newly created holding company, Great American NewCo, providing a clear ...

Forbes does not accept payment for placement on lists.

Rights Aug 16, 2024 Aug 16, 2024 Jun 12, 2024 Rights ratio: 3 share for every 2 held at a price of Rs 10.0 Rights Mar 21, 2023 Mar 22, 2023 Dec 29, 2022 Rights ratio: 8 share for every 5 held at a ...

Upon the close of the transaction, BlackRock, Inc. was renamed BlackRock Finance, Inc. and a NewCo became the publicly listed company with the name BlackRock, Inc. Additional information ...